You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 5,945,525

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,945,525

Title:	Method for isolating nucleic acids using silica-coated magnetic particles
Abstract:	A nucleic acid-bondable magnetic carrier of the present invention is a magnetic silica particle comprising a superparamagnetic metal oxide, wherein the magnetic silica particle has a specific surface of about 100 to about 800 m.sup.2 /g.
Inventor(s):	Uematsu; Hiroaki (Ohtsu, JP), Daimon; Katsuya (Ohtsu, JP), Yoshiga; Satoko (Ohtsu, JP)
Assignee:	Toyo Boseki Kabushiki Kaisha (Osaka, JP)
Application Number:	08/676,982
Patent Claims:	1. A method for isolating a polynucleotide comprising the steps of: (1) mixing a polynucleotide-bondable magnetic particle with a solution containing a polynucleotide and a solution of a chaotropic agent, wherein said magnetic particle is a composite of a superparamagnetic metal oxide and a fine silica and wherein the specific surface of said magnetic particle is about 100 to about 800 square meters per gram; (2) separating the magnetic carrier to which the nucleic acid has been bonded from the sample solution using a magnetic field; and (3) eluting the polynucleotide from the magnetic carrier to which the nucleic acid has been bonded. 2. A method for isolating a polynucleotide according to claim 1, wherein the magnetic particle is spherical. 3. A method for isolating a polynucleotide according to claim 1, wherein the superparamagnetic metal oxide is iron oxide. 4. The method for isolating a polynucleotide according to claim 1, wherein the magnetic particle contains from about 10 to about 60 percent by weight of the superparamagnetic metal oxide. 5. The method for isolating a polynucleotide according to claim 1, wherein the magnetic particle has an average surface pore diameter of about 0.1 to about 60 nm and has a pore volume of about 0.01 to about 1.5 mL/g. 6. The method for isolating a polynucleotide according to claim 1, wherein the magnetic particle has a particle diameter of about 0.5 to about 15 micrometers. 7. The method for isolating a polynucleotide according to claim 1, wherein the chaotropic agent is selected from the group consisting of guanidine salt, sodium iodide, potassium iodide, sodium thiocyanate, sodium isothiocyanate, urea and combinations thereof. 8. The method for isolating a polynucleotide according to claim 1, wherein the polynucleotide is a plasmid or an amplified polynucleotide. 9. The method for isolating a polynucleotide according to claim 1, where an elution buffer is used in the eluting step. 10. The method for isolating a polynucleotide according to claim 1, wherein the buffer is TE buffer. 11. The method for isolating a polynucleotide according to claim 1, wherein the eluting is performed with sterile water. 12. A kit for isolating a polynucleotide comprising a magnetic silica particle and a chaotropic agent, wherein said magnetic silica particle is a composite of a superparamagnetic metal oxide and fine silica and wherein said magnetic silica particle possesses a specific surface of about 100 to about 800 square meters per gram.

Details for Patent 5,945,525

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006	⤷ Try a Trial	2039-09-23
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.